Find a Study
Cardiovascular
Lipoprotein
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], a type of cholesterol-related particle linked to cardiovascular risk.
Weight Loss
Overweight Study
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating an investigational once-weekly injectable medication for weight management.
Weight Loss
Obesity/Overweight Study
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating an investigational once-weekly injectable medication for weight management.
Weight Loss
Obesity Study
Adults who are overweight or obese and currently using semaglutide (Ozempic®/Wegovy®) or tirzepatide (Mounjaro®/Zepbound®) may qualify for a research study evaluating an investigational weight loss medication.
Can't find a study that fits your needs? Explore other Atlas Clinical Research studies in locations all around the United States.
